Doria-Rose, Nicole
- National Institute of Allergy and Infectious Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,530
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.5M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#2,530
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Doria-Rose, Nicole as a PI. Multi-PI records show the full award amount for context.
- 1ZIAAI005095-16ZIAContact PIHIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants$1.5Maward amount
- 1ZICAI005010-22ZICContact PIQuantitative Immunological Assays to Assess HIV Antibodies and Vaccines$892.4Kaward amount
- 1ZICAI005169-02ZICContact PIQuantitative Immunological Assays to Assess SARS-CoV-2 Antibodies and Vaccines$100Kaward amount
Award organization
Organizations that administered FY2023 awards listing Doria-Rose, Nicole as a PI.
FY2023 award administered by National Institute of Allergy and Infectious Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardNational Institute of Allergy and Infectious Diseases
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #2530
- 2023Entered Top 25% NationallyRanked #2530